OHR Pharmaceutical, Inc. (OHRP) Reaches $2.34 After 5.00% Down Move; Dover Downs Gaming & Entertainment (DDE) Sellers Increased By 11.85% Their Shorts

OHR Pharmaceutical, Inc. (NASDAQ:OHRP) Logo

Dover Downs Gaming & Entertainment Inc (NYSE:DDE) had an increase of 11.85% in short interest. DDE’s SI was 2.87M shares in March as released by FINRA. Its up 11.85% from 2.57 million shares previously. With 126,800 avg volume, 23 days are for Dover Downs Gaming & Entertainment Inc (NYSE:DDE)’s short sellers to cover DDE’s short positions. The SI to Dover Downs Gaming & Entertainment Inc’s float is 18.15%. The stock increased 1.15% or $0.03 during the last trading session, reaching $2.65. About 32,865 shares traded. Dover Downs Gaming & Entertainment, Inc. (NYSE:DDE) has risen 110.08% since March 14, 2018 and is uptrending. It has outperformed by 105.71% the S&P500. Some Historical DDE News: 26/04/2018 – Dover Downs 1Q Rev $43.2M; 19/04/2018 DJ Dover Downs Gaming & Entertainment , Inst Holders, 1Q 2018 (DDE); 26/04/2018 – Dover Downs 1Q Loss/Shr 1c

The stock of OHR Pharmaceutical, Inc. (NASDAQ:OHRP) is a huge mover today! The stock decreased 4.49% or $0.11 during the last trading session, reaching $2.34. About 57,172 shares traded. OHR Pharmaceutical, Inc. (NASDAQ:OHRP) has declined 50.81% since March 14, 2018 and is downtrending. It has underperformed by 55.18% the S&P500.The move comes after 8 months negative chart setup for the $6.62M company. It was reported on Mar, 14 by Barchart.com. We have $2.22 PT which if reached, will make NASDAQ:OHRP worth $331,000 less.

More notable recent Dover Downs Gaming & Entertainment, Inc. (NYSE:DDE) news were published by: Seekingalpha.com which released: “Dover Downs bid up 51% on merger euphoria – Seeking Alpha” on July 23, 2018, also Seekingalpha.com with their article: “Dover And Twin River Will Keep Surprising – Seeking Alpha” published on July 26, 2018, Seekingalpha.com published: “Dover Downs Gaming & Entertainment, Inc. (DDE) CEO Denis McGlynn on Q4 2018 Results – Earnings Call Transcript – Seeking Alpha” on January 24, 2019. More interesting news about Dover Downs Gaming & Entertainment, Inc. (NYSE:DDE) were released by: Seekingalpha.com and their article: “Select gaming stocks active after buyout action – Seeking Alpha” published on November 28, 2018 as well as Globenewswire.com‘s news article titled: “New Research: Key Drivers of Growth for Aurora Cannabis, CGI Group, Keurig Dr Pepper, Scorpio Bulkers, Dover Downs Gaming & Entertainment, and Lee Enterprises — Factors of Influence, Major Initiatives and Sustained Production – GlobeNewswire” with publication date: November 16, 2018.

Investors sentiment decreased to 1 in Q4 2018. Its down 0.70, from 1.7 in 2018Q3. It worsened, as 3 investors sold Dover Downs Gaming & Entertainment, Inc. shares while 5 reduced holdings. 1 funds opened positions while 7 raised stakes. 10.13 million shares or 3.60% more from 9.77 million shares in 2018Q3 were reported. Renaissance Techs Limited Liability Corporation has 0% invested in Dover Downs Gaming & Entertainment, Inc. (NYSE:DDE) for 776,200 shares. Ancora Advsrs Ltd Liability Co holds 249,000 shares. Geode Mgmt Ltd Limited Liability Company holds 0% or 155,826 shares. Standard General Limited Partnership reported 46,060 shares or 0.06% of all its holdings. National Bank Of America De stated it has 0% of its portfolio in Dover Downs Gaming & Entertainment, Inc. (NYSE:DDE). Northern Trust Corporation reported 57,533 shares or 0% of all its holdings. Polar Asset Prtn has 1.66 million shares. Venator Cap Ltd owns 1.66M shares. Vanguard Gp Inc has invested 0% in Dover Downs Gaming & Entertainment, Inc. (NYSE:DDE). Deutsche Bancshares Ag stated it has 0% in Dover Downs Gaming & Entertainment, Inc. (NYSE:DDE). State Street Corporation invested in 10,513 shares. Gabelli Funds Ltd Liability Corporation holds 0% or 125,000 shares in its portfolio. Nantahala Capital Ltd Liability Corp has invested 0.1% in Dover Downs Gaming & Entertainment, Inc. (NYSE:DDE). Par Cap invested in 0.04% or 915,000 shares. Lafitte Cap Mgmt L P stated it has 1.03% of its portfolio in Dover Downs Gaming & Entertainment, Inc. (NYSE:DDE).

Dover Downs Gaming & Entertainment, Inc., together with its subsidiaries, operates as a gaming and entertainment resort destination in the United States. The company has market cap of $88.20 million. The firm operates Dover Downs Casino, a 165,000-square foot casino complex with table games, including craps, roulette, and card games; slot machine games; multi-player electronic table games; a poker room; and a race and sports book operation, as well as bars, restaurants, and six retail outlets. It has a 2650 P/E ratio. It also operates the Dover Downs Hotel and Conference Center, a 500 room AAA Four Diamond hotel with fine dining restaurant, spa/salon, conference, banquet, ballroom, and concert hall facilities; and Dover Downs Raceway, a harness racing track with pari-mutuel wagering on live and simulcast horse races.

Investors sentiment decreased to 0.5 in Q4 2018. Its down 0.50, from 1 in 2018Q3. It dropped, as 4 investors sold OHR Pharmaceutical, Inc. shares while 8 reduced holdings. 3 funds opened positions while 3 raised stakes. 4.23 million shares or 20.01% less from 5.29 million shares in 2018Q3 were reported. Wells Fargo And Mn reported 167 shares. Vanguard Grp Inc holds 0% or 531,931 shares in its portfolio. Huntington National Bank & Trust has invested 0% in OHR Pharmaceutical, Inc. (NASDAQ:OHRP). New York-based Blackrock Incorporated has invested 0% in OHR Pharmaceutical, Inc. (NASDAQ:OHRP). Renaissance Technologies Ltd Liability Corporation stated it has 1.98 million shares or 0% of all its holdings. Geode Capital Mgmt Lc, a Massachusetts-based fund reported 268,161 shares. Royal National Bank Of Canada reported 410 shares. Creative Planning reported 68,000 shares stake. Savings Bank Of Ny Mellon Corp owns 33,472 shares or 0% of their US portfolio. Garrison Bradford And Assoc Inc, New York-based fund reported 101,000 shares. Paloma Prtnrs Mgmt invested in 76,400 shares or 0% of the stock. Leisure Cap Management stated it has 57,921 shares. Northern Trust Corporation reported 135,564 shares. California Employees Retirement Systems owns 78,800 shares. 128,277 are owned by Virtu Financial.

OHR Pharmaceutical, Inc., a pharmaceutical company, focuses on the development of novel therapeutics and delivery technologies for the treatment of ocular disease. The company has market cap of $6.62 million. The Company’s lead clinical program is topical Squalamine, a small molecule anti-angiogenic drug, which could provide a non-invasive therapy to enhance vision outcomes. It currently has negative earnings. The firm is evaluating Squalamine, which completed Phase II clinical trials for the treatment of retinal diseases, including wet-AMD, proliferative diabetic retinopathy, and retinal vein occlusion.

More notable recent OHR Pharmaceutical, Inc. (NASDAQ:OHRP) news were published by: Globenewswire.com which released: “Ohr Pharmaceutical Regains Compliance with NASDAQ Listing Requirements – GlobeNewswire” on February 21, 2019, also Nasdaq.com with their article: “NeuBase Therapeutics Announces Agreements for $9 Million Financing – Nasdaq” published on March 11, 2019, Seekingalpha.com published: “Ohr Pharma up 23% ahead of merger vote – Seeking Alpha” on March 06, 2019. More interesting news about OHR Pharmaceutical, Inc. (NASDAQ:OHRP) were released by: Nasdaq.com and their article: “Ohr Pharmaceutical Reports Financial Results for the Fiscal First Quarter of 2019 – Nasdaq” published on February 14, 2019 as well as Benzinga.com‘s news article titled: “26 Stocks Moving In Thursday’s Pre-Market Session – Benzinga” with publication date: March 07, 2019.

Dover Downs Gaming & Entertainment, Inc. (NYSE:DDE) Institutional Positions Chart